 | Up a level |
Journal Article
Al-Shehab, T., Starck, C., Raskopf, E., Kelber, O., Nieber, K. and Moesges, R. (2021). Gender data from the PhytoVIS study, a pharmaco-epidemiological NIS more than 20.000 patients. Planta Med., 87 (15). S. 1267 - 1269. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-0221
Becker, S., Zieglmayer, P., Canto, G., Fassio, F., Yong, P., Acikel, C., Raskopf, E., Steveling, E., Allekotte, S. and Moesges, R. (2020). Clinical efficacy and safety profile of allergen-specific immunotherapy using microcrystalline tyrosine (MCT)-adsorbed allergoids - A meta-analysis. Allergy, 75. S. 275 - 276. HOBOKEN: WILEY. ISSN 1398-9995
Liedtke, J. -P., Mandl, A., Koether, J., Chwieralski, J., Shah-Hosseini, K., Raskopf, E., Pieper-Fuerst, U., Allekotte, S. and Moesges, R. (2018). RCAT reflects symptom control and quality of life in allergic rhinoconjunctivitis patients. Allergy, 73 (5). S. 1101 - 1110. HOBOKEN: WILEY. ISSN 1398-9995
Mischer, N., Kelber, O., Raskopf, E., Frohne, I, Richter, J. G. and Nieber, K. (2022). Phytotherapy for pain: data from the PhytoVIS study, a NIS in 20,870 users of herbal medicinal products. Planta Med., 88 (15). S. 1561 - 1562. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-0221
Moeller, J., Kelber, O., Raskopf, E., Nieber, K. and Grundmann, O. (2021). Comparison of epidemiological data on functional GI diseases under an herbal therapy from non-interventional studies in the US and Germany. Planta Med., 87 (15). S. 1267 - 1268. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-0221
Moesges, R., Kasche, E. M., Raskopf, E., Singh, J., Sohlich, L., Astvatsatourov, A., Shah-Hosseini, K., Pirotton, S., Haazen, L., Durham, S. R., Legon, T., Zadoyan, G. and Shamji, M. H. (2018). A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy. Allergy, 73 (4). S. 896 - 905. HOBOKEN: WILEY. ISSN 1398-9995
Moesges, R., Koch, A. F., Raskopf, E., Singh, J., Shah-Hosseini, K., Astvatsatourov, A., Hauswald, B., Yarin, Y., Corazza, F., Haazen, L., Pirotton, S., Allekotte, S., Zadoyan, G., Legon, T., Durham, S. R. and Shamji, M. H. (2018). Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients. Allergy, 73 (6). S. 1254 - 1263. HOBOKEN: WILEY. ISSN 1398-9995